Skip to content
MarketScale
‹ Back to IndustriesHealthcare

MarketScale Explores The Business of Healthcare at ViVE 2023

MarketScale is headed to Nashville, Tennessee this year, to join senior and executive leadership in the digital healthcare space at ViVE 2023.   Held at the Music City Center, this event hopes to provide attendees with an individualized connection process, personalized programming and plenty of growth opportunities to be discovered over the course of four days…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

MarketScale is headed to Nashville, Tennessee this year, to join senior and executive leadership in the digital healthcare space at

ViVE

2023

.

Held at the Music City Center, this event hopes to provide attendees with an individualized connection process, personalized programming and plenty of

growth opportunities

to be discovered over the course of four days in Nashville.

From health plans to

big tech

getting in on the healthcare business, we get an inside look at the subjects that will be a topic of conversation for everyone who attends from

David Kemp

, Healthcare Lead at MarketScale.

David’s Thoughts

“What’s up, everybody? It’s David Kemp. I’m your host of the

Highway to Health

podcast series. I also lead the healthcare vertical at MarketScale.

I can’t wait to see how the ViVE community comes together and continues building the momentum they established in their inaugural event last year, there are three things I’m looking for from the ViVE event this year. If you’ve looked at the speakers, it’s the who’s who of healthcare. You have small startups that are innovating and disrupting the industry, and then you have big tech companies that are talking about how they can bring what they’ve learned from other industries to healthcare to help solve some of the challenges that we all know.

But what I’m looking forward to is seeing how health plans, these payer groups, they’ve put themselves front and center and I can’t wait to see how they bridge a gap for the providers. If you’ve been paying attention, you know that these health plans have seen record profits in 2022. While conversely, the provider has struggled with reimbursement, profit margin, with operating margin, so how do these payers come together and say, this is our vision forward?

This is our path forward together. Number two we live in the golden age of innovation. And some of these companies are looking forward to sharing how they are disrupting healthcare. But what I’m looking forward to is the response, the opinion, and the perception that the community has towards big tech.

In the past, we’ve been a little hesitant with companies like Salesforce and

Amazon

and these other big technology companies coming into healthcare. But we’ve gotten past that a little bit and you’re starting to see them gain traction, gain momentum in a lot of ways. They’re going to be front and center as well at ViVE, and I can’t wait to see not only what they have to say, but how the healthcare community perceives, accepts, and starts to adopt some of these innovative technologies that these big tech companies are coming to the market with.

Third, there’s a lot of focus on preventative care this year, but what are we really talking about in preventative care? Are we talking about increased access to the patient community so they can get the care that they need when they need it? Are we talking about an early diagnosis? So that we can catch some of these chronic diseases and conditions earlier and can treat them more effectively.

Or are we talking about preventative care through the lens of wellness and health and healthy habits? Hopefully, all three of those things are considered and talked about in starting to be implemented in healthcare so that we can truly prevent some of the chronic conditions and huge health events that our patient population has.

Those events are putting a tremendous amount of stress on our providers and our payers. So I’m looking forward to that conversation. If you’ve tuned into Highway to Health I’m focused on this open road journey that we’re all on together to improve this industry that we love so much.

And hopefully, the village can come together. Because that’s what it’s going to take us. It’s going to take all of us. Hopefully, we can start coming together. At the ViVE event, begin solving some of these challenges and get the industry where we want it to be. I’ll see you there.”

Article written by Gabrielle Bejarano

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512